ArticleJournal of ophthalmic inflammation and infection2013
Sympathetic ophthalmia: to the twenty-first century and beyond.
Article in Journal of ophthalmic inflammation and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 116 citations in OpenAlex.
- Ocular immune homeostasis-mechanisms of precise regulation through coordination of the eye, visual system and beyond: a narrative review.Annals of eye science · 2026Article
- Increased risk of sympathetic ophthalmia in ocular surgical patients with trauma history.International ophthalmology · 2025Article
- Anophthalmic Sockets: A Retrospective Review of Enucleations, Eviscerations, and Exenterations Performed and Managed in a Tertiary Care Hospital.Journal of clinical medicine · 2025Article
- Long-Term Management of Sympathetic Ophthalmia Developing in the Early Period Following Trauma: A Case Report.Cureus · 2025Article
- Sympathetic Ophthalmia Following an Evisceration Surgery-A Case Report.Clinical case reports · 2024Article
- Article
- Long-term clinical outcomes of patients with sympathetic ophthalmia.International ophthalmology · 2024Article
- Cutting-edge issues in sympathetic ophthalmia approach and six case reports: a T cell-mediated autoimmune response.Arquivos brasileiros de oftalmologia · 2024Review
- Material risk: vitreoretinal surgery, evisceration, enucleation and sympathetic ophthalmia-where are we currently?Eye (London, England) · 2023Review
- Sympathetic ophthalmia in an 85-year-old female and a 90-year-old male after a non-complicated cataract surgery: a case report.The Journal of international medical research · 2023Article
- Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results.Turkish journal of ophthalmology · 2023Article
- Corneal Endothelial Cell Loss after Ciliary Sulcus Placement of Ahmed Glaucoma Valve in Patients with Noninfectious Uveitic Glaucoma.Journal of personalized medicine · 2022Article
- Sympathetic ophthalmia: A comprehensive update.Indian journal of ophthalmology · 2022Review
- Evisceration and enucleation cases in the ophthalmologic emergency department of a tertiary Brazilian hospital.Arquivos brasileiros de oftalmologia · 2022Article
- Risk Factors for Enucleation Following Open Globe Injury: A 17-Year Experience.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Sympathetic ophthalmia following blunt injury to phthisical eye.BMJ case reports · 2021Article
- Sympathetic ophthalmia after 27-G pars plana vitrectomy.BMC ophthalmology · 2021Article
- Blinding ocular trauma caused by remote controlled aerial drone.BMJ case reports · 2021Article
- An Atypical Presentation of Sympathetic Ophthalmia in an Intact Globe Following Mechanical Fall: A Case Report and Literature Review.Vision (Basel, Switzerland) · 2021Article
- Methotrexate Effectively Controls Ocular Inflammation in Japanese Patients With Non-infectious Uveitis.Frontiers in medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Sympathetic ophthalmia is a rare bilateral granulomatous inflammation that follows accidental or surgical insult to the uvea of one eye. Onset of sympathetic ophthalmia can be insidious or acute, with recurrent periods of exacerbation. Clinical presentation shows mutton-fat keratic precipitates, choroidal infiltrations, and Dalen-Fuchs nodules. Histopathology reveals diffuse or nodular granulomatous inflammation of the uvea. Prevention and treatment strategies for sympathetic ophthalmia are currently limited to two modalities, enucleation of the injured eye and immunosuppressive therapy, aimed at controlling inflammation. The etiology and pathophysiology of the disease is still unclear but is largely thought to be autoimmune in nature. Recent insight on the molecular pathology of the disease as well as developments in imaging technology have furthered both the understanding on the autoimmune process in sympathetic ophthalmia and the targeting of prevention and treatment strategies for the future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.